Goldman Sachs’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,789
| Closed | -$71K | – | 4827 |
|
|
2024
Q2 | $71K | Sell |
26,789
-13,262
| -33% | -$35.1K | ﹤0.01% | 4533 |
|
|
2024
Q1 | $110K | Buy |
+40,051
| New | +$110K | ﹤0.01% | 4450 |
|
|
2023
Q3 | – | Sell |
-17,416
| Closed | -$51.4K | – | 4729 |
|
|
2023
Q2 | $51.4K | Sell |
17,416
-112,173
| -87% | -$331K | ﹤0.01% | 4671 |
|
|
2023
Q1 | $324K | Sell |
129,589
-40,415
| -24% | -$101K | ﹤0.01% | 4293 |
|
|
2022
Q4 | $539K | Buy |
170,004
+10,304
| +6% | +$32.7K | ﹤0.01% | 4055 |
|
|
2022
Q3 | $474K | Sell |
159,700
-421,303
| -73% | -$1.25M | ﹤0.01% | 4286 |
|
|
2022
Q2 | $1.77M | Buy |
581,003
+500,662
| +623% | +$1.53M | ﹤0.01% | 3528 |
|
|
2022
Q1 | $1.08M | Sell |
80,341
-18,305
| -19% | -$247K | ﹤0.01% | 4042 |
|
|
2021
Q4 | $1.29M | Buy |
98,646
+12,613
| +15% | +$164K | ﹤0.01% | 3835 |
|
|
2021
Q3 | $807K | Buy |
86,033
+27,459
| +47% | +$258K | ﹤0.01% | 4120 |
|
|
2021
Q2 | $600K | Sell |
58,574
-1,514
| -3% | -$15.5K | ﹤0.01% | 4332 |
|
|
2021
Q1 | $1.11M | Buy |
+60,088
| New | +$1.11M | ﹤0.01% | 3829 |
|
|
2020
Q4 | – | Sell |
-179,933
| Closed | -$3.32M | – | 4633 |
|
|
2020
Q3 | $3.32M | Buy |
+179,933
| New | +$3.32M | ﹤0.01% | 2632 |
|